In keeping with our commitment to delivering a healthier future, Vyteris is continually researching and developing new ways to expand the scientific and human benefits of non-invasive drug delivery. To read the latest news about Vyteris, please click on any of the articles below.

Press Releases
10/08/2002 B. Braun Medical Inc. and Vyteris, Inc Sign Marketing Agreement - Leader in regional anesthesia to market Vyteris transdermal lidocaine system

06/04/2002 Vyteris, Inc. Submits New Drug Application to FDA For 'Pain Patch' Lidocaine-Delivery System - Vyteris, Inc. announced today that it submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA)

05/06/2002 Stopping the 'Ouch'! Vyteris's 'Pain Patch' Promises Relief for Kids Fearing Shots or Needle Injections - A new pain patch for children was tested in clinical trials and found to decrease pain from a needle injection by approximately 40%

07/18/2001 "Myths About How Children Experience and Handle Pain Still Abound," Survey Finds - Parents Say They Shrug it off, but Survey Reveals Guilt, Worry and a Strong Desire for Pain Relief

03/07/2001 Vyteris Inc. is Created as Becton Dickinson Divests Transdermal Drug Delivery Unit - Advances in Transdermal Drug Delivery Offer Alternative to Pills and Injections


 
Home Company Technology Products Partnering Careers News
 
© 2003 Vyteris. All Rights Reserved.